Once mostly limited to straight-line motion, “biohybrid” bots are finally getting the hang of more complex motion.
Get the latest international news and world events from around the world.
Optimizing Gene Editing with PARP1 CRISPR Plasmids
Gene editing is revolutionizing the understanding of health and disease, providing researchers with vast opportunities to advance the development of novel treatment approaches. Traditionally, researchers used various methods to introduce double strand breaks (DSBs) into the genome, including transactivator-like effectors, meganucleases, and zinc finger nucleases. While useful, these techniques are limited in that they are time and labor intensive, less efficient, and can have unintended effects. In contrast, the clustered regularly interspaced short palindromic repeat (CRISPR)-associated protein-9 (Cas9) system (CRISPR/Cas9) is among the most sensitive and efficient methods for creating DNA DSBs, making it the leading gene editing technology.
CRISPR/Cas9 is a naturally occurring immune protective process that bacteria use to destroy foreign genetic material.1 Researchers repurposed the CRISPR/Cas9 system for genetic engineering applications in mammalian cells, exploiting the molecular processes that introduce DSBs in specific sections of DNA, which are then repaired to turn certain genes on or off, or to correct genomic errors with extraordinary precision.2,3 This technology’s applications are far reaching, from cell culture and animal models to translational research that focuses on correcting genetic mutations in diseases such as cancer, hemophilia, and sickle cell disease.4
Researchers exploit plasmids, the small, closed circular DNA strands native to bacteria, as delivery vehicles in CRISPR/Cas9 gene editing protocols. Plasmids shuttle the CRISPR/Cas9 gene editing components to target cells and can be manipulated to control gene editing activity, including targeting multiple genes at a time. Plasmids can also deliver gene repair instructions and machinery. For example, poly (ADP-ribose) polymerase 1 (PARP1) is an enzyme that drives DNA repair and transcription.5 It is a critical aspect of CRISPR/Cas9 gene editing technology in part because it helps repair the DSBs created by the CRISPR/Cas9 system. PARP1 CRISPR plasmids can edit, knockout, or upregulate PARP1 gene expression depending on the specific instructions encoded in the plasmid.
Can quantum hints in the brain revive a radical consciousness theory?
With anaesthetics and brain organoids, we are finally testing the idea that quantum effects explain consciousness – and the early results suggest this long-derided idea may have been misconstrued.
Elon Musk confirms a new low-cost Tesla model is coming in 2025
Tesla is reportedly working on compact crossover EV codenamed “Redwood” with production set to start in June 2025, sources familiar with the matter told Reuters. The company is said to have sent requests for quotes for the new model to suppliers last year, predicting a weekly production volume of 10,000 vehicles.
Elon Musk has confirmed that a “next-generation low-cost” Tesla EV is in the works and is “optimistic” that it’ll arrive in the second half of 2025, he said in an earnings call yesterday. He also promised “a revolutionary manufacturing system” for the vehicle that’s far more advanced than any others in the world by a “significant margin.”
An article yesterday from Reuters indicated that the new vehicle would be a small crossover codenamed “Redwood.” Tesla reportedly sent requests to suppliers for quotes, predicting a weekly production volume of 10,000 vehicles. Musk previously stated that the automaker is working on two new EV models that could sell up to 5 million per year, combined.
“Our current schedule shows that we will start production towards the end of 2025, sometime in the second half,” he said on the call. The vehicle will be built in Tesla’s Austin, Texas Gigafactory to start with and other locations around the world later. Musk hinted that there would be a strong push to ramp up assembly: “We’ll be sleeping on the line practically,” he said.
Researchers discovered high-order skyrmions and antiskyrmions
Study opens up new paradigm in skyrmionics research.
Farmbots, flavour pills and zero-gravity beer: inside the mission to grow food in space
Astronauts content themselves with freeze-dried gruel, but plans for crewed missions to Mars mean scientists need to create more delicious, nutritious menus by James Shackell.
Photographer snaps extremely rare ‘green flash’ coming from Venus
A brief flash of green light was recently spotted coming from Venus in the night sky. The colorful shimmer has only been seen a handful of times before.
No brain, no problem. Jellyfish learn just fine
Despite lacking a centralized brain, the translucent creatures can learn from past experiences to avoid bumping into obstacles.
Scientists turn glass into a ‘transparent’ semiconductor with laser
The team was thrilled with this discovery and saw the potential for creating durable patterns on the glass surface that could produce electricity when illuminated. This is a significant breakthrough because the technique does not require any additional materials, and all that is needed is tellurite glass and a femtosecond laser to create an active photoconductive material.
“Tellurium being semiconducting, based on this finding we wondered if it would be possible to write durable patterns on the tellurite glass surface that could reliably induce electricity when exposed to light, and the answer is yes,” explains Yves Bellouard who runs EPFL’s Galatea Laboratory.
Age Reversal Pill Coming SOON? David Sinclair’s NEW RESEARCH
Dr. David Sinclair’s groundbreaking research indicates a pill capable of reversing aging at a cellular level is possible and that even a high school student…








